Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy

Abstract

Purpose

Choroidal neovascularization (CNV) is a rare complication after laser photocoagulation for disorders such as central serous chorioretinopathy (CSC).

Methods

We report 2 patients who developed CNV after laser treatment for persistent CSC and were treated by 3 1.25-mg intravitreal injections of bevacizumab in 1-month intervals.

Results

In both patients, best-corrected visual acuity improved from 20/120 to 20/80 and from counting fingers at 3 feet to 20/100 over 12 months of follow-up.

Conclusions

The favorable outcome suggests that intravitreal injection of bevacizumab may be beneficial for patients who develop CNV after laser photocoagulation. The favorable outcome may be related to the limited pathology.

Keywords

Argon laser photocoagulation Bevacizumab Central serous chorioretinopathy Chorioretinal scar Choroidal neovascularization Intravitreal injection

Get full access to this article

View all access options for this article.

References

Gass

J.D.M.

. Photocoagulation treatment of idiopathic central serous retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 456-63.

Matsunaga

, Nangoh

, Uyama

, Nanbu

, Fujiseki

, Takahashi

. Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy. Nippon Ganka Gakkai Zasshi 1995; 99: 460-8.

T.W.

, Ham

D.I.

, Kang

S.W.

. Management of choroidal neovascularization following laser photocoagulation for central serous chorioretinopathy. Korean J Ophthalmol 2002; 16: 88-92.

Chan

W.M.

, Li

K.K.

, Liu

D.T.

, Lai

T.Y.

, Chong

K.K.

, Lam

D.S.

. Photodynamic therapy with verteporfin in laser-induced choroidal neovascularization. Am J Ophthalmol 2003; 136: 565-7.

Landers

M.B.

III , Shaw

H.E.

Jr , Anderson

W.B.

Jr , Sinyai

A.J.

. Argon laser treatment of central serous chorioretinopathy. Ann Ophthalmol 1977; 9: 1567-72.